Published in J Clin Microbiol on September 01, 1995
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother (1997) 9.16
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 4.10
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol (1998) 2.27
A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One (2009) 2.15
Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect Immun (1997) 2.09
Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.94
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother (2003) 1.93
igr Genes and Mycobacterium tuberculosis cholesterol metabolism. J Bacteriol (2009) 1.82
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis. J Biol Chem (2003) 1.62
Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 1.53
Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel) (2012) 1.43
Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother (2001) 1.40
Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrob Agents Chemother (1996) 1.39
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase. Antimicrob Agents Chemother (2000) 1.24
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography. Antimicrob Agents Chemother (2007) 1.20
Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis (2003) 1.19
Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol (1999) 1.16
Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening. Chem Biol (2012) 1.13
Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis. J Clin Microbiol (2000) 1.12
Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye. J Clin Microbiol (2007) 1.09
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol (1998) 1.09
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli. J Bacteriol (1999) 1.03
Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. Clin Diagn Lab Immunol (2004) 1.03
Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob Agents Chemother (1997) 0.99
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2006) 0.97
Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs. J Infect Dis (2014) 0.94
The antibacterial effect of ethanol extract of polish propolis on mutans streptococci and lactobacilli isolated from saliva. Evid Based Complement Alternat Med (2013) 0.90
Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Mol Oral Microbiol (2011) 0.87
Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11. Antimicrob Agents Chemother (2006) 0.86
Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis. J Clin Microbiol (2004) 0.85
Microplate alamarBlue assay for Paracoccidioides susceptibility testing. J Clin Microbiol (2013) 0.82
Identification of small-molecule scaffolds for p450 inhibitors. Curr Protoc Microbiol (2010) 0.81
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2015) 0.80
Evaluation of the modified colorimetric resazurin microtiter plate-based antibacterial assay for rapid and reliable tuberculosis drug susceptibility testing. BMC Microbiol (2014) 0.78
In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains. Antimicrob Agents Chemother (1998) 0.77
Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates. Eur J Clin Microbiol Infect Dis (2011) 0.76
Understanding HIV-Mycobacteria synergism through comparative proteomics of intra-phagosomal mycobacteria during mono- and HIV co-infection. Sci Rep (2016) 0.76
Resazurin tube method: rapid, simple, and inexpensive method for detection of drug resistance in the clinical isolates of mycobacterium tuberculosis. J Glob Infect Dis (2014) 0.75
Synthesis, Antimicrobial and cytotoxic activity of New Heterocyclic Hybrids Based on 2,5-Dimethylpyrrole and Pyrrole Scaffolds. Indian J Pharm Sci (2013) 0.75
Rapid screening of inhibitors of Mycobacterium tuberculosis growth using tetrazolium salts. Methods Mol Biol (2009) 0.75
Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am Rev Respir Dis (1987) 3.86
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol (1994) 3.46
A rapid method for determining the drug susceptibility of Mycobacterium tuberculosis. Am Rev Tuberc (1958) 1.80
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol (1998) 6.26
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis (2001) 4.19
Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. Clin Infect Dis (1994) 3.30
Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 3.17
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother (1998) 3.00
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 2.92
Myocardial changes associated with cardiogenic shock. N Engl J Med (1971) 2.67
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood (1999) 2.59
Rapid confirmatory identification of Neisseria gonorrhoeae with lectins and chromogenic substrates. J Clin Microbiol (1984) 2.58
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med (1988) 2.33
Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest (1996) 2.31
Infection-control guidelines for patients with the acquired immunodeficiency syndrome (AIDS). N Engl J Med (1983) 2.26
Human infection with Edwardsiella tarda. Ann Intern Med (1969) 2.25
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. J Clin Microbiol (1985) 2.21
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65). J Clin Microbiol (1989) 2.04
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother (1995) 2.01
Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation (1972) 1.94
High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis (1994) 1.93
Quantitative culture of Mycobacterium tuberculosis from clinical sputum specimens and dilution endpoint of its detection by the Amplicor PCR assay. J Clin Microbiol (1995) 1.89
Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. J Clin Invest (1972) 1.74
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1987) 1.73
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab (1993) 1.66
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.66
Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci. J Clin Microbiol (1985) 1.65
Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med (1995) 1.62
Successive bacteremias with "Campylobacter cinaedi" and "Campylobacter fennelliae" in a bisexual male. J Clin Microbiol (1987) 1.60
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. Antimicrob Agents Chemother (1987) 1.55
Diagnosis and surgical treatment of mitral regurgitation secondary to ruptured chordae tendineae. N Engl J Med (1967) 1.54
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53
Autopsy findings with permanent pervenous pacemakers. Circulation (1969) 1.53
Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1988) 1.52
Bacterial characterization by flow cytometry. Science (1983) 1.52
Recurrence of group B streptococcal infection. J Pediatr (1976) 1.48
Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation (1973) 1.40
Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol (1990) 1.39
Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Arch Intern Med (1992) 1.38
Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Am Rev Respir Dis (1989) 1.37
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation (1972) 1.35
The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis (1994) 1.34
Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med (1993) 1.32
In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrob Agents Chemother (1982) 1.30
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria. Antimicrob Agents Chemother (1981) 1.29
An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med (1982) 1.27
The immunological competence of subjects with sarcoidosis. Clin Exp Immunol (1974) 1.26
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis (1990) 1.25
Sequential atrioventricular pacing in heart block complicating acute myocardial infarction. N Engl J Med (1970) 1.25
Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis (1999) 1.25
Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1989) 1.23
Human fecal flora under controlled diet intake. Am J Clin Nutr (1970) 1.23
Clinical trial comparing bacitracin with Strep-A-Chek for accuracy and turnaround time in the presumptive identification of Streptococcus pyogenes. J Clin Microbiol (1986) 1.23
Paravalvular leaks and hemolytic anemia following insertion of Starr-Edwards aortic and mitral valves. J Thorac Cardiovasc Surg (1968) 1.23
The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch Pathol Lab Med (1989) 1.20
Mechanical circulatory assistance. Current status and experience with combining circulatory assistance, emergency coronary angiography, and acute myocardial revascularization. Circulation (1972) 1.19
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. Antimicrob Agents Chemother (1990) 1.19
Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob Agents Chemother (1992) 1.17
The medical treatment of dissecting aortic aneurysms. N Engl J Med (1972) 1.16
Antibody to the retrovirus associated with the acquired immunodeficiency syndrome (AIDS). Presence in presumably healthy San Franciscans who died unexpectedly. Arch Intern Med (1986) 1.15
Penicillin-resistant Streptococcus constellatus as a cause of endocarditis. Am J Dis Child (1982) 1.15
Therapy of dissecting aneurysms. Arch Surg (1967) 1.14
Biochemical properties of CO2-dependent streptococci. J Clin Microbiol (1980) 1.14
Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol (1983) 1.13
Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1986) 1.11
Study of human renal disease by immunofluorescent methods. Arch Pathol (1967) 1.10
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. Antimicrob Agents Chemother (1992) 1.09
Incomplete relaxation between beats after myocardial hypoxia and ischemia. J Clin Invest (1974) 1.09
Use of the transbronchial biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol (1984) 1.08
Permanent endocardial pacing in complete heart block. Assessment of the technique and the advantages in 20 patients. Ann Intern Med (1967) 1.07
Surgery for complications of acute myocardial infarction. Circulation (1972) 1.07
Traumatic myocardial infarction. Report of a case with normal coronary angiogram. Ann Intern Med (1967) 1.06
Effects of intra-aortic balloon counterpulsation on cardiac performance, oxygen consumption, and coronary blood flow in dogs. Circ Res (1970) 1.06
Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol (1983) 1.06
Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis. J Infect Dis (1985) 1.05
In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun (1973) 1.04
Mitral regurgitation in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1966) 1.04
Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS (1998) 1.04
Cardiac hemodynamics immediately following mitral valve surgery. J Thorac Cardiovasc Surg (1966) 1.03
Recovery of Bordetella bronchiseptica from patients with AIDS. Clin Infect Dis (1992) 1.02
Preparative isotachophoretic separation of skin test antigens from blastomycin purified derivative. Infect Immun (1976) 1.02
Penicillin tolerance in experimental streptococcal endocarditis. Lancet (1979) 1.01
Bordetella pertussis versus non-L. pneumophila Legionella spp.: a continuing diagnostic challenge. J Clin Microbiol (1992) 1.01
Effect of storage temperature and pH on the stability of antimicrobial agents in MIC trays. J Clin Microbiol (1986) 1.01
Cardiac hemodynamics immediately following aortic valve surgery. J Thorac Cardiovasc Surg (1966) 1.00
Connective tissue abnormalities in spontaneous rupture of chordae tendineae. Arch Pathol (1971) 1.00
Surgical therapy for early complications of myocardial infarction. Surgery (1971) 1.00
An assessment of radial haemolysis in the detection of rubella antibody. J Clin Pathol (1978) 0.99
Role of renin in acute postural homeostasis. Circulation (1970) 0.99
Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wall. Infect Immun (1976) 0.99